218 related articles for article (PubMed ID: 34681667)
41. Clinical manifestation and phenotypic analysis of novel gene mutation in 28 Chinese children with hereditary spherocytosis.
Xie F; Lei L; Cai B; Gan L; Gao Y; Liu X; Zhou L; Jiang J
Mol Genet Genomic Med; 2021 Apr; 9(4):e1577. PubMed ID: 33620149
[TBL] [Abstract][Full Text] [Related]
42. [Hereditary spherocytosis: one year study of erythrocyte membrane proteins].
Tshilolo L; Kagambega F; Sztern B; Vertongen F; Gulbis B
Rev Med Brux; 1998 Oct; 19(5 Pt 1):417-23. PubMed ID: 9844481
[TBL] [Abstract][Full Text] [Related]
43. Hereditary spherocytosis overlooked for 7 years in a pediatric patient with β-thalassemia trait and novel compound heterozygous mutations of SPTA1 gene.
Chen M; Ye YP; Liao L; Deng XL; Qiu YL; Lin FQ
Hematology; 2020 Dec; 25(1):438-445. PubMed ID: 33210974
[No Abstract] [Full Text] [Related]
44. A new frameshift mutation of the β-spectrin gene associated with hereditary spherocytosis.
Bogusławska DM; Heger E; Machnicka B; Skulski M; Kuliczkowski K; Sikorski AF
Ann Hematol; 2017 Jan; 96(1):163-165. PubMed ID: 27709257
[No Abstract] [Full Text] [Related]
45. Hereditary spherocytosis with spectrin deficiency related to null mutations of the beta-spectrin gene.
Dhermy D; Galand C; Bournier O; Cynober T; Méchinaud F; Tchemia G; Garbarz M
Blood Cells Mol Dis; 1998 Jun; 24(2):251-61. PubMed ID: 9714702
[TBL] [Abstract][Full Text] [Related]
46. Murine recessive hereditary spherocytosis, sph/sph, is caused by a mutation in the erythroid alpha-spectrin gene.
Wandersee NJ; Birkenmeier CS; Gifford EJ; Mohandas N; Barker JE
Hematol J; 2000; 1(4):235-42. PubMed ID: 11920196
[TBL] [Abstract][Full Text] [Related]
47. Novel α-spectrin mutation in trans with α-spectrin causing severe neonatal jaundice from hereditary spherocytosis.
Nussenzveig RH; Christensen RD; Prchal JT; Yaish HM; Agarwal AM
Neonatology; 2014; 106(4):355-7. PubMed ID: 25277063
[TBL] [Abstract][Full Text] [Related]
48. Neonatal hereditary spherocytosis caused by a de novo frameshift mutation of the SPTB gene characterized by hydrops fetalis: A case report.
Zhang Y; Shao S; Liu J; Zeng C; Han Y; Zhang X
Medicine (Baltimore); 2021 Mar; 100(12):e24804. PubMed ID: 33761640
[TBL] [Abstract][Full Text] [Related]
49. Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry.
Vives-Corrons JL; Krishnevskaya E; Rodriguez IH; Ancochea A
Int J Hematol; 2021 Feb; 113(2):163-174. PubMed ID: 33074480
[TBL] [Abstract][Full Text] [Related]
50. Clinical and molecular evaluation of non-dominant hereditary spherocytosis.
Miraglia del Giudice E; Nobili B; Francese M; D'Urso L; Iolascon A; Eber S; Perrotta S
Br J Haematol; 2001 Jan; 112(1):42-7. PubMed ID: 11167781
[TBL] [Abstract][Full Text] [Related]
51. Targeted next-generation sequencing identifies a novel nonsense mutation in SPTB for hereditary spherocytosis: A case report of a Korean family.
Shin S; Jang W; Kim M; Kim Y; Park SY; Park J; Yang YJ
Medicine (Baltimore); 2018 Jan; 97(3):e9677. PubMed ID: 29505016
[TBL] [Abstract][Full Text] [Related]
52. beta-Spectrin S(ta) Bárbara: a novel frameshift mutation in hereditary spherocytosis associated with detectable levels of mRNA and a germ cell line mosaicism.
Bassères DS; Duarte AS; Hassoun H; Costa FF; Saad ST
Br J Haematol; 2001 Nov; 115(2):347-53. PubMed ID: 11703334
[TBL] [Abstract][Full Text] [Related]
53. Molecular diagnosis of hereditary spherocytosis by multi-gene target sequencing in Korea: matching with osmotic fragility test and presence of spherocyte.
Choi HS; Choi Q; Kim JA; Im KO; Park SN; Park Y; Shin HY; Kang HJ; Kook H; Kim SY; Kim SJ; Kim I; Kim JY; Kim H; Park KD; Park KB; Park M; Park SK; Park ES; Park JA; Park JE; Park JK; Baek HJ; Seo JH; Shim YJ; Ahn HS; Yoo KH; Yoon HS; Won YW; Lee KS; Lee KC; Lee MJ; Lee SA; Lee JA; Lee JM; Lee JH; Lee JW; Lim YT; Jung HJ; Chueh HW; Choi EJ; Jung HL; Kim JH; Lee DS;
Orphanet J Rare Dis; 2019 May; 14(1):114. PubMed ID: 31122244
[TBL] [Abstract][Full Text] [Related]
54. Whole-exome sequencing for the genetic diagnosis of congenital red blood cell membrane disorders in Taiwan.
Lin PC; Chiou SS; Lin CY; Wang SC; Huang HY; Chang YS; Tseng YH; Kan TM; Liao YM; Tsai SP; Peng CT; Chang JG
Clin Chim Acta; 2018 Dec; 487():311-317. PubMed ID: 30317022
[TBL] [Abstract][Full Text] [Related]
55. Novel mutations in patients with hereditary red blood cell membrane disorders using next-generation sequencing.
He Y; Jia S; Dewan RK; Liao N
Gene; 2017 Sep; 627():556-562. PubMed ID: 28694211
[TBL] [Abstract][Full Text] [Related]
56. Abnormal oxidant sensitivity and beta-chain structure of spectrin in hereditary spherocytosis associated with defective spectrin-protein 4.1 binding.
Becker PS; Morrow JS; Lux SE
J Clin Invest; 1987 Aug; 80(2):557-65. PubMed ID: 3611357
[TBL] [Abstract][Full Text] [Related]
57. Next-generation sequencing identified a novel SPTB frameshift insertion causing hereditary spherocytosis in China.
Meng LL; Yuan SM; Tu CF; Lin G; Lu GX; Tan YQ
Ann Hematol; 2019 Jan; 98(1):223-226. PubMed ID: 29961904
[No Abstract] [Full Text] [Related]
58. Identification of a novel p.Q1772X ANK1 mutation in a Korean family with hereditary spherocytosis.
Han JH; Kim S; Jang H; Kim SW; Lee MG; Koh H; Lee JH
PLoS One; 2015; 10(6):e0131251. PubMed ID: 26107955
[TBL] [Abstract][Full Text] [Related]
59. Molecular basis of spectrin deficiency in beta spectrin Durham. A deletion within beta spectrin adjacent to the ankyrin-binding site precludes spectrin attachment to the membrane in hereditary spherocytosis.
Hassoun H; Vassiliadis JN; Murray J; Yi SJ; Hanspal M; Ware RE; Winter SS; Chiou SS; Palek J
J Clin Invest; 1995 Dec; 96(6):2623-9. PubMed ID: 8675627
[TBL] [Abstract][Full Text] [Related]
60. Next generation sequencing (NGS) interest in deciphering erythrocyte molecular defects' association in red cell disorders: Clinical and erythrocyte phenotypes of patients with mutations inheritance in PIEZO1, Spectrin ß1, RhAG and SLC4A1.
Allegrini B; NGuyen LD; Mignotet M; Etchebest C; Fenneteau O; Platon J; Lambilliotte A; Guizouarn H; Da Costa L
Blood Cells Mol Dis; 2023 Nov; 103():102780. PubMed ID: 37516005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
